Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC

D. De Ruysscher; A. Dingemans; J. Praag; J. Belderbos; C. Tissing-Tan; G. Herder; T. Haitjema; F. Ubbels; F. Lagerwaard; J. Stigt; E. Smit; H. Van Tinteren; V. Van der Noort; H. Groen

doi:10.1016/S0167-8140(18)31675-X

Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC

D. De Ruysscher, A. Dingemans, J. Praag, J. Belderbos, C. Tissing-Tan, G. Herder, T. Haitjema, F. Ubbels, F. Lagerwaard, J. Stigt, E. Smit, H. Van Tinteren, V. Van der Noort, H. Groen

Research output: Contribution to journal › Meeting Abstract › Academic

210 Downloads (Pure)

Original language	English
Article number	EP-1366
Pages (from-to)	S745-S746
Number of pages	2
Journal	Radiotherapy and Oncology
Volume	127
Issue number	Suppl.1
DOIs	https://doi.org/10.1016/S0167-8140(18)31675-X
Publication status	Published - Apr-2018
Event	37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) - Barcelona, Spain Duration: 20-Apr-2018 → 24-Apr-2018

Access to Document

10.1016/S0167-8140(18)31675-XLicence: CC BY-NC-ND

Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLCFinal publisher's version, 666 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

De Ruysscher, D., Dingemans, A., Praag, J., Belderbos, J., Tissing-Tan, C., Herder, G., Haitjema, T., Ubbels, F., Lagerwaard, F., Stigt, J., Smit, E., Van Tinteren, H., Van der Noort, V., & Groen, H. (2018). Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC. Radiotherapy and Oncology, 127(Suppl.1), S745-S746. Article EP-1366. https://doi.org/10.1016/S0167-8140(18)31675-X

@article{2e7d1a81d2be4c2e9f77831cde5f7ac2,

title = "Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC",

author = "{De Ruysscher}, D. and A. Dingemans and J. Praag and J. Belderbos and C. Tissing-Tan and G. Herder and T. Haitjema and F. Ubbels and F. Lagerwaard and J. Stigt and E. Smit and {Van Tinteren}, H. and {Van der Noort}, V. and H. Groen",

year = "2018",

month = apr,

doi = "10.1016/S0167-8140(18)31675-X",

language = "English",

volume = "127",

pages = "S745--S746",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "ELSEVIER IRELAND LTD",

number = "Suppl.1",

note = "37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) ; Conference date: 20-04-2018 Through 24-04-2018",

}

De Ruysscher, D, Dingemans, A, Praag, J, Belderbos, J, Tissing-Tan, C, Herder, G, Haitjema, T, Ubbels, F, Lagerwaard, F, Stigt, J, Smit, E, Van Tinteren, H, Van der Noort, V & Groen, H 2018, 'Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC', Radiotherapy and Oncology, vol. 127, no. Suppl.1, EP-1366, pp. S745-S746. https://doi.org/10.1016/S0167-8140(18)31675-X

TY - JOUR

T1 - Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC

AU - De Ruysscher, D.

AU - Dingemans, A.

AU - Praag, J.

AU - Belderbos, J.

AU - Tissing-Tan, C.

AU - Herder, G.

AU - Haitjema, T.

AU - Ubbels, F.

AU - Lagerwaard, F.

AU - Stigt, J.

AU - Smit, E.

AU - Van Tinteren, H.

AU - Van der Noort, V.

AU - Groen, H.

PY - 2018/4

Y1 - 2018/4

U2 - 10.1016/S0167-8140(18)31675-X

DO - 10.1016/S0167-8140(18)31675-X

M3 - Meeting Abstract

SN - 0167-8140

VL - 127

SP - S745-S746

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - Suppl.1

M1 - EP-1366

T2 - 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)

Y2 - 20 April 2018 through 24 April 2018

ER -